Twist Bioscience Corporation (TWST) — Financial statements
Income statement, balance sheet, and cash flow for Twist Bioscience Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 377↑20.3% | 313↑27.7% | 245↑20.4% | 204↑53.8% | 132 | |
| Cost of Revenue | 186↑3.3% | 180↑15.6% | 155↑30.2% | 119↑48.0% | 81 | |
| Gross Profit | 191↑43.2% | 133↑48.6% | 90↑6.5% | 84↑62.9% | 52 | |
| Operating Expenses | ||||||
| R&D Expenses | 80↓11.6% | 91↓15.0% | 107↓11.1% | 120↑74.2% | 69 | |
| General & Administrative Expenses | 240 | 0.00↓100.0% | 187 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 7 | 0.00↓100.0% | 3 | 0.00 | 0.00 | |
| SG&A Expenses | 247↑13.1% | 218↑15.1% | 190↓10.9% | 213↑56.7% | 136 | |
| Other Expenses | 0.00↓100.0% | 45↑338.1% | 10↑172.0% | -14↓2567.6% | -0.53 | |
| Operating Expenses | 327↓7.6% | 354↑15.4% | 307↓3.8% | 319↑56.0% | 204 | |
| Total Costs & Expenses | 513↓3.9% | 534↑15.5% | 462↑5.5% | 438↑53.8% | 285 | |
| Operating Results | ||||||
| Operating Income | -136↑38.3% | -221↓1.7% | -217↑7.5% | -235↓53.7% | -153 | |
| Depreciation & Amortization | 25↓20.9% | 31↑7.2% | 29↑77.5% | 17↑69.4% | 10 | |
| EBITDA | -52↑70.5% | -177↓1.5% | -174↑17.7% | -212↓47.1% | -144 | |
| EBIT | -77↑63.0% | -208↓2.3% | -203↑10.8% | -228↓48.5% | -154 | |
| Interest & Other Income | ||||||
| Net Interest Income | 11↓25.8% | 15↑6.7% | 14↑381.6% | 3↑4285.3% | 0.07 | |
| Interest Income | 11↓25.9% | 15↑6.8% | 14↑369.1% | 3↑603.9% | 0.44 | |
| Interest Expense | 0.00↓100.0% | 0.03↑480.0% | 0.01↓93.8% | 0.08↓78.2% | 0.37 | |
| Non-Operating Income | -59↓367.2% | -13↑7.3% | -14↓108.1% | -7↓804.0% | 0.94 | |
| Other Income / Expenses | 59↑368.3% | 13↓7.5% | 14↑110.6% | 7↑599.4% | -1 | |
| Income Before Tax | -77↑63.0% | -208↓2.3% | -203↑10.9% | -228↓48.2% | -154 | |
| Income Tax Expense | 0.72↑28.4% | 0.56↓51.4% | 1↑111.1% | -10↓439.4% | -2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -78↑62.8% | -209↓2.0% | -205↑6.1% | -218↓43.2% | -152 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -78↑62.8% | -209↓2.0% | -205↑6.1% | -218↓43.2% | -152 | |
| Bottom-Line Net Income | -78↑62.8% | -209↓2.0% | -205↑6.1% | -218↓43.2% | -152 | |
| EPS (Basic) | -1.30↑63.9% | -3.60↑0.0% | -3.60↑10.9% | -4.04↓28.3% | -3.15 | |
| EPS (Diluted) | -1.30↑63.9% | -3.60↑0.0% | -3.60↑10.9% | -4.04↓28.3% | -3.15 | |
| Weighted Average Shares | 60↑3.1% | 58↑2.0% | 57↑5.6% | 54↑11.7% | 48 | |
| Weighted Average Diluted Shares | 60↑3.1% | 58↑2.0% | 57↑5.6% | 54↑11.7% | 48 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.